Related Experiment Video
Updated: Oct 8, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification
Hideyuki Kawashima1, Patrick W Serruys2, Hironori Hara1
1Department of Cardiology, National University of Ireland, Galway, Galway, Ireland; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Insights
Heavily calcified lesions (HCLs) independently predict 10-year mortality after coronary revascularization. The choice between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) did not significantly impact outcomes in patients with HCLs.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Limited long-term outcome data exist for patients with heavily calcified lesions (HCLs) undergoing revascularization.
- Understanding the impact of HCLs on mortality after percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) is crucial for treatment decisions.
Purpose of the Study:
- To assess 10-year all-cause mortality in patients with HCLs treated with PCI or CABG.
- To determine if HCLs are an independent predictor of long-term mortality.
- To investigate the interaction between HCLs and revascularization strategy on mortality.
Main Methods:
- A substudy of the SYNTAX trial, including 1,800 patients with 3-vessel and/or left main disease randomized to PCI or CABG.
- Patients were analyzed based on the presence or absence of HCLs (lesions with >50% diameter stenosis).
- 10-year all-cause mortality was compared between groups, with adjustments for baseline characteristics and interaction analysis.
Main Results:
- Patients with at least one HCL had significantly higher 10-year mortality (36.4%) compared to those without HCLs (22.3%).
- HCLs remained an independent predictor of 10-year mortality after adjustment (HR: 1.36).
- While PCI showed higher mortality than CABG in patients without HCLs, no significant difference was observed in patients with HCLs.
Conclusions:
- The presence of HCLs is an independent predictor of 10-year mortality following coronary revascularization.
- Prognosis appears similar between PCI and CABG in patients with HCLs.
- Further evaluation is needed to determine if HCLs warrant special consideration beyond their current role in anatomical scoring for revascularization decisions.
Objectives:
The aim of this study was to assess 10-year all-cause mortality in patients with heavily calcified lesions (HCLs) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Background:
Limited data are available on very long term outcomes in patients with HCLs according to the mode of revascularization.
Methods:
This substudy of the SYNTAXES (Synergy Between PCI With Taxus and Cardiac Surgery Extended Survival) study assessed 10-year all-cause mortality according to the presence of HCLs within lesions with >50% diameter stenosis and identified during the calculation of the anatomical SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score among 1,800 patients with the 3-vessel disease and/or left main disease randomized to PCI or CABG in the SYNTAX trial. Patients with HCLs were further stratified according to disease type (3-vessel disease or left main disease) and assigned treatment (PCI or CABG).
Results:
The 532 patients with ≥1 HCL had a higher crude mortality rate at 10 years than those without (36.4% vs 22.3%; HR: 1.79; 95% CI: 1.49-2.16; P < 0.001). After adjustment, an HCL remained an independent predictor of 10-year mortality (HR: 1.36; 95% CI: 1.09-1.69; P = 0.006). There was a significant interaction in mortality between treatment effect (PCI and CABG) and the presence or absence of HCLs (Pinteraction = 0.005). In patients without HCLs, mortality was significantly higher after PCI than after CABG (26.0% vs 18.8%; HR: 1.44; 95% CI: 0.97-1.41; P = 0.003), whereas in those with HCLs, there was no significant difference (34.0% vs 39.0%; HR: 0.85; 95% CI: 0.64-1.13; P = 0.264).
Conclusions:
At 10 years, the presence of an HCL was an independent predictor of mortality, with a similar prognosis following PCI or CABG. Whether HCLs require special consideration when deciding the mode of revascularization beyond their current contribution to the anatomical SYNTAX score deserves further evaluation. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES], NCT03417050; SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries [SYNTAX], NCT00114972).
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

